Mason Street Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,198
Closed -$2.89M 1285
2020
Q4
$2.89M Sell
10,198
-173
-2% -$49K 0.05% 436
2020
Q3
$2.85M Sell
10,371
-137
-1% -$37.7K 0.06% 373
2020
Q2
$2.39M Sell
10,508
-28,847
-73% -$6.55M 0.05% 431
2020
Q1
$5.99M Hold
39,355
0.14% 135
2019
Q4
$5.92M Buy
39,355
+679
+2% +$102K 0.11% 166
2019
Q3
$5.49M Sell
38,676
-492
-1% -$69.8K 0.11% 173
2019
Q2
$4.9M Sell
39,168
-282
-0.7% -$35.3K 0.1% 198
2019
Q1
$4.35M Buy
39,450
+647
+2% +$71.3K 0.09% 230
2018
Q4
$3.8M Buy
38,803
+1,033
+3% +$101K 0.09% 210
2018
Q3
$4.66M Buy
37,770
+33
+0.1% +$4.07K 0.1% 205
2018
Q2
$3.75M Buy
37,737
+576
+2% +$57.2K 0.08% 242
2018
Q1
$3.28M Buy
37,161
+579
+2% +$51.1K 0.08% 286
2017
Q4
$3.61M Sell
36,582
-148
-0.4% -$14.6K 0.08% 261
2017
Q3
$3.54M Buy
36,730
+799
+2% +$76.9K 0.08% 240
2017
Q2
$3.4M Buy
35,931
+1,322
+4% +$125K 0.09% 264
2017
Q1
$2.82M Buy
34,609
+453
+1% +$37K 0.07% 316
2016
Q4
$2.9M Buy
34,156
+279
+0.8% +$23.7K 0.08% 291
2016
Q3
$2.52M Buy
33,877
+551
+2% +$41.1K 0.07% 321
2016
Q2
$2.53M Buy
33,326
+1,832
+6% +$139K 0.07% 310
2016
Q1
$2.18M Buy
31,494
+1,300
+4% +$90.1K 0.07% 353
2015
Q4
$1.82M Buy
30,194
+585
+2% +$35.2K 0.06% 422
2015
Q3
$1.6M Buy
29,609
+19,671
+198% +$1.06M 0.05% 454
2015
Q2
$577K Buy
9,938
+445
+5% +$25.8K 0.02% 883
2015
Q1
$572K Sell
9,493
-161,650
-94% -$9.74M 0.02% 885
2014
Q4
$9.11M Buy
171,143
+324
+0.2% +$17.3K 0.06% 361
2014
Q3
$7.65M Sell
170,819
-64
-0% -$2.87K 0.06% 372
2014
Q2
$7.2M Buy
170,883
+1,294
+0.8% +$54.5K 0.06% 398
2014
Q1
$7.47M Sell
169,589
-2,519
-1% -$111K 0.06% 369
2013
Q4
$8.44M Buy
172,108
+161,848
+1,577% +$7.94M 0.07% 339
2013
Q3
$422K Buy
10,260
+676
+7% +$27.8K ﹤0.01% 1153
2013
Q2
$337K Buy
+9,584
New +$337K ﹤0.01% 1120